FR2152507A1 - - Google Patents

Info

Publication number
FR2152507A1
FR2152507A1 FR7206562A FR7206562A FR2152507A1 FR 2152507 A1 FR2152507 A1 FR 2152507A1 FR 7206562 A FR7206562 A FR 7206562A FR 7206562 A FR7206562 A FR 7206562A FR 2152507 A1 FR2152507 A1 FR 2152507A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7206562A
Other languages
French (fr)
Other versions
FR2152507B1 (en:Method
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2152507A1 publication Critical patent/FR2152507A1/fr
Application granted granted Critical
Publication of FR2152507B1 publication Critical patent/FR2152507B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7206562A 1971-09-10 1972-02-25 Expired FR2152507B1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1329871A CH563405A5 (en:Method) 1971-09-10 1971-09-10

Publications (2)

Publication Number Publication Date
FR2152507A1 true FR2152507A1 (en:Method) 1973-04-27
FR2152507B1 FR2152507B1 (en:Method) 1975-04-25

Family

ID=4391173

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7206562A Expired FR2152507B1 (en:Method) 1971-09-10 1972-02-25

Country Status (11)

Country Link
US (1) US3832341A (en:Method)
JP (1) JPS4834195A (en:Method)
BE (1) BE785575A (en:Method)
CA (1) CA972747A (en:Method)
CH (1) CH563405A5 (en:Method)
DE (1) DE2160104A1 (en:Method)
DK (1) DK130685B (en:Method)
FR (1) FR2152507B1 (en:Method)
GB (1) GB1317075A (en:Method)
NL (1) NL7200191A (en:Method)
SE (1) SE399268B (en:Method)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2186470A1 (en) * 1972-05-30 1974-01-11 Henning Berlin Gmbh Purine nucleoside nitrates - for treating cardiac insufficiency
EP0004261A3 (en) * 1978-02-01 1979-11-28 F.Hoffmann-La Roche & Co. Aktiengesellschaft Imidazole derivatives, method and intermediates for their preparation and pharmaceutical compositions containing such imidazole derivatives, as well as the use of such imidazole derivatives in combating diseases

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104462A (en) * 1975-02-18 1978-08-01 Hoffmann-La Roche Inc. Cardioactive adenosine nitrates
US4122172A (en) * 1975-03-18 1978-10-24 Byk Gulden Lomberg Chemische Fabrik Gmbh β-D-1-(6-amino-9H-purin-9-yl)-1-deoxy-2,3-di-O-nitroribofuranuronethylamide
AT350735B (de) * 1976-08-06 1979-06-11 Hoffmann La Roche Verfahren zur herstellung von neuen ribo- furanosyl-imidazolderivaten
JPS53123993A (en) * 1977-04-04 1978-10-28 Horiba Ltd Water sampler for water quality measuring apparatus
JPS5767190U (en:Method) * 1980-10-08 1982-04-22
EP1758596B9 (en) 2004-05-26 2010-09-15 Inotek Pharmaceuticals Corporation Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
CA2581132A1 (en) * 2004-09-20 2006-03-30 Inotek Pharmaceuticals Corporation Purine 5'-carboxamide derivatives and their use as adenosine receptor agonists
DE102005043031A1 (de) * 2005-09-10 2007-03-15 Mauer, Dieter, Dr. Verfahren zum Entfernen von Phosphaten aus Acetat-gepufferten Lösungen
EP1962597A4 (en) * 2005-11-30 2008-12-17 Inotek Pharmaceuticals Corp PURINE DERIVATIVES AND METHOD OF USE
SG182285A1 (en) 2010-01-11 2012-08-30 Inotek Pharmaceuticals Corp Combination, kit and method of reducing intraocular pressure
BR112012023749A2 (pt) 2010-03-26 2016-08-23 Inotek Pharmaceuticals Corp método para reduzir a pressão intraocular em humanos utilizando n6-ciclopentiladenosina (cpa), derivados de cpa ou pró-fármacos desses
SI2794627T1 (sl) 2011-12-22 2019-02-28 Alios Biopharma, Inc. Substituirani nukleozidi, nukleotidi in njihovi analogi
CN104093731B (zh) 2012-01-26 2017-05-24 伊诺泰克制药公司 [(2r,3s,4r,5r)‑5‑(6‑(环戊基氨基)‑9h‑嘌呤‑9‑基)‑3,4‑二羟基四氢呋喃‑2‑基)]甲基硝酸酯的无水多晶型物及其制备方法
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
NZ630759A (en) 2013-03-15 2017-07-28 Inotek Pharmaceuticals Corp Ophthalmic formulations comprising an a1 agonist
EP2876166B1 (en) 2013-11-20 2016-12-14 Roche Diagnostics GmbH New compound for sequencing by synthesis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595853A (en) * 1968-03-19 1971-07-27 Kohjin Co Ribofuranosyl cytosine and arabinofuranosyl cytosine derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595853A (en) * 1968-03-19 1971-07-27 Kohjin Co Ribofuranosyl cytosine and arabinofuranosyl cytosine derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2186470A1 (en) * 1972-05-30 1974-01-11 Henning Berlin Gmbh Purine nucleoside nitrates - for treating cardiac insufficiency
EP0004261A3 (en) * 1978-02-01 1979-11-28 F.Hoffmann-La Roche & Co. Aktiengesellschaft Imidazole derivatives, method and intermediates for their preparation and pharmaceutical compositions containing such imidazole derivatives, as well as the use of such imidazole derivatives in combating diseases

Also Published As

Publication number Publication date
FR2152507B1 (en:Method) 1975-04-25
DE2160104A1 (de) 1973-03-22
DK130685B (da) 1975-03-24
SE399268B (sv) 1978-02-06
CH563405A5 (en:Method) 1975-06-30
GB1317075A (en) 1973-05-16
US3832341A (en) 1974-08-27
NL7200191A (en:Method) 1973-03-13
DK130685C (en:Method) 1975-09-08
BE785575A (fr) 1972-12-29
CA972747A (en) 1975-08-12
JPS4834195A (en:Method) 1973-05-16

Similar Documents

Publication Publication Date Title
DK130685C (en:Method)
ATA136472A (en:Method)
AR196074A1 (en:Method)
AU2952271A (en:Method)
AU2894671A (en:Method)
AU2941471A (en:Method)
AU3005371A (en:Method)
AU442402B2 (en:Method)
AU2963771A (en:Method)
AU1109576A (en:Method)
AU2455871A (en:Method)
AU2875571A (en:Method)
AR192311Q (en:Method)
AU2880771A (en:Method)
AU2885171A (en:Method)
AU2907471A (en:Method)
AU2837671A (en:Method)
AU2927871A (en:Method)
AU2399971A (en:Method)
AU2415871A (en:Method)
AU2930871A (en:Method)
AU2938071A (en:Method)
AU2940971A (en:Method)
AU2854371A (en:Method)
AU2836771A (en:Method)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse